Gold Silver Reports – Lupin Gains After Receiving Green Signal From FDA — Lupin Gains After Receiving Green Signal From FDA – Shares of the drug maker extended gains for the fourth straight trading session, the longest winning streak in over two months. The stock rose a much as 1 percent to Rs 813.05.
The pharmaceutical company received tentative U.S. FDA approval for generic AndroGel, according to its stock exchange notification.
The stock has declined 42.5 percent over the past year, compared to 18.9 percent in the country’s benchmark Sensex.
